Table 1.
Baseline characteristic | Vitamin D group | Placebo group | P |
---|---|---|---|
Age (mean±SD) | 42.24±12.26 | 40.06±13.37 | 0.571 |
Weight (mean±SD) | 66.15±9.37 | 66.28±12.39 | 0.968 |
BMI (mean±SD) | 25.85±3.78 | 25.27±4.07 | 0.619 |
Smoking (%) | 0 | 2 (8.7) | 0.489 |
Vitamin D consumption (%) | 0 | 0 | 1.00 |
SSS (mean±SD) | 250.87±96.92 | 245.78±112.82 | 0.737 |
IBS-QOL (mean±SD) | 57.35±27.96 | 46.70±31.37 | 0.231 |
Total score (mean±SD) | 81.30±15.17 | 80.00±13.40 | 0.759 |
Significances are based on independent t-test for quantitative variables and Pearson’s Chi-squared test/Fisher exact test for qualitative factors. SSS=Symptoms severity score, QOL=Quality of life, SD=Standard deviation, IBS=Irritable bowel syndrome, BMI=Body mass index